Tissue Stem Cell-Based Therapies in Parkinson’s Disease: A Scoping Review of Therapeutic Mechanisms and Translational Outcomes
Cells · 2025
DOI: 10.3390/cells14110822 ↗Kurz gefasst
Scoping Review in der Zeitschrift Cells, 2025. Verfasst von Emily Cueva und 6 weiteren Autor:innen. Beteiligte Einrichtung: NeurALL Research Group, Quito 170157, Ecuador. Hauptthemen laut MEDLINE: Parkinson Disease, Stem Cell Transplantation, Translational Research, Biomedical, Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de las Américas (UDLA).
Abstract (Originalsprache)
(1)
Background
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterised by dopaminergic neuronal loss. Tissue stem cell-based therapies have emerged as promising candidates for disease modification and symptomatic relief. This scoping review aims to systematically synthesise the literature on tissue stem cell therapies for PD across cellular, animal, and human studies, with a focus on transplantation strategies, mechanisms of action, and therapeutic outcomes. (2)
Methods
We identified 1017 records by querying PubMed, Scopus, Cochrane, and the Virtual Health Library. After screening and applying eligibility criteria, 33 experimental studies were included. Data were extracted on study design, tissue stem cell source, type of subject, and therapeutic effects. (3)
Results
Most studies (n = 25) involved animal models, with a minority (n = 8) focusing on human applications. Tissue stem cell therapies showed potential to promote dopaminergic differentiation, reduce inflammation and apoptosis, and improve behavioural and motor outcomes. Autologous transplants yielded a higher safety and efficacy compared to allogeneic ones. The beneficial mechanisms of tissue stem cells included neurotrophic support, mitochondrial protection, modulation of the gut–brain axis, and α-synuclein clearance. (4)
Conclusions
Tissue stem cell therapies represent a promising approach for PD. However, standardised protocols and long-term safety assessments are essential to optimise their translational potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NeurALL Research Group, Quito 170157, Ecuador.
- School of Psychology, University College Dublin, D04 V1W8 Dublin, Ireland.
- Escuela de Psicología, Universidad Espíritu Santo, Samborondón 092301, Ecuador.
- Cerebro, Emoción y Conducta (CEC) Research Group, Medical School, Universidad de las Américas (UDLA), Quito 170124, Ecuador.
ORCID-Profile: Jailene González, Sabine Falconi, Jose A Rodas, Jose E Leon-Rojas
Förderung
- Universidad de las Américas (UDLA)
Zitieren
APA
Cueva, E., Wiesheu, A., Sordo, Z., González, J., Falconi, S., Rodas, J. A., & Leon-Rojas, J. E. (2025). Tissue Stem Cell-Based Therapies in Parkinson’s Disease: A Scoping Review of Therapeutic Mechanisms and Translational Outcomes. Cells. https://doi.org/10.3390/cells14110822
Vancouver
Cueva E, Wiesheu A, Sordo Z, González J, Falconi S, Rodas JA, et al. Tissue Stem Cell-Based Therapies in Parkinson’s Disease: A Scoping Review of Therapeutic Mechanisms and Translational Outcomes. Cells. 2025. doi:10.3390/cells14110822
BibTeX
@article{Cueva2025,
author = {Cueva, Emily and Wiesheu, Andrea and Sordo, Zaira and González, Jailene and Falconi, Sabine and Rodas, Jose A and Leon-Rojas, Jose E},
title = {Tissue Stem Cell-Based Therapies in Parkinson’s Disease: A Scoping Review of Therapeutic Mechanisms and Translational Outcomes},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14110822}
}
EUVIMED